- $903.45m
- $3.46bn
- $4.19bn
- 35
- 92
- 33
- 53
Annual income statement for Calumet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,268 | 3,148 | 4,686 | 4,181 | 4,189 |
| Cost of Revenue | |||||
| Gross Profit | 210 | 143 | 352 | 452 | 231 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,340 | 3,234 | 4,596 | 3,920 | 4,182 |
| Operating Profit | -71.9 | -85.6 | 90.5 | 261 | 7.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -148 | -259 | -170 | 49.7 | -221 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -149 | -260 | -173 | 48.1 | -222 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -149 | -260 | -173 | 48.1 | -222 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -146 | -255 | -170 | 47.1 | -222 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.81 | -3.07 | -0.666 | -0.908 | -2.48 |